The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search instagram avvo phone envelope checkmark mail-reply spinner error close The Legal Examiner The Legal Examiner The Legal Examiner
Skip to main content
Double exposure of scientist with equipment and science experiments ,laboratory glassware containing chemical liquid

On January 29, the online pharmacy Valisure released data supporting links between the once-popular heartburn medicine Zantac and cancer. This comes after USDA reported on the existence of the contaminant NDMA in Zantac and generic ranitidine products issued a recall of every single ranitidine drug on the market. NDMA is actually much more than a contaminant – it also is a carcinogen. The World Health Organization has stated that NDMA may cause colorectal cancer in humans when consumed in large volumes over a long period of time.

The Valisure study, published in Journal of the American Medical Association (JAMA) Network Open, suggests Sanofi’s Zantac and other ranitidine drugs can cause the suspected cancer agent N-Nitrosodimethylamine (NDMA) to form under a range of conditions, including in the human body. According to Valisure founder and CEO David Light, the studies by the pharmacy support “decades of research that ranitidine is fundamentally unstable, can form NDMA in a variety of conditions including in the human body and could be carcinogenic and toxic to humans.

This latest study further supports earlier research that has linked NDMA to bladder cancer, colorectal cancer, gastric cancer, pancreatic cancer and stomach cancer and tumors in the kidneys, liver and lungs. Consumers exposed to NDMA could experience additional symptoms including abdominal cramps, dizziness, fever, headaches, jaundice, nausea and vomiting. Other adverse events associated with NDMA are arrhythmia (irregular heartbeat) and tachycardia (rapid heartbeat), hair loss and skin rashes, nervous-system disorders and vitamin-B12 deficiencies.

Zantac lawsuits and Zantac class-action lawsuits are being filed in courts around the country. Plaintiffs have claimed that the manufacturers knew or should have known about the presence of NDMA in their products but failed to warn consumers or healthcare providers. Zantac was a popular and widely distributed drug and at Saunders & Walker we believe that there could be thousands of potential claims against these companies that are worth billions in compensation for the consumers harmed by this dangerous drug.

Saunders & Walker continues to advocate for the welfare of people who have suffered injury from negligence by the corporate medical device and pharmaceutical drug industry. If you or a loved one took Zantac or a generic equivalent and have been diagnosed with cancer, please contact Saunders & Walker at 1-800-748-7115 for a free consultation to review your case and help determine your best legal options for pursuing justice and compensation. See our website below for more information on Zantac.


Zantac Lawsuit Cases





Comments for this article are closed.